3

HILLHOUSE CAPITAL MANAGEMENT, LTD.

Company: Apellis Pharmaceuticals, Inc.
Filed: November 8, 2017
Period of Report: November 8, 2017
Accession Number: 0000902664-17-004240

View Document ↗ View on SEC.gov ↗